The location of FAM227B, 15q21.2, was found to be associated with oral cancer. The 15q21.2 locus is mentioned in other literature as well.  FGF7 is a neighbour of FAM227B in the 15q21.2 locus (rs10519227), and encodes for the fibroblast growth factor, which is involved in processes such as embryonic development, cell growth, tissue repair, tumor growth, invasion, and morphogenesis. FGF works as a signal for thyroid gland development, and an SNP on intron 2 of FGF7 has been associated with thyroid growth/goiter growth. This association was only significant at the genome level in males. It was found that the abnormal goiter growth is likely due to variant signals that cause increased levels of TSH. FAM227B was found to be related to at least some of the 48 significant DMRs (differentially methylated regions) between HF (high fertile) and LF (low fertile) groups in the genome of spermatozoa from boar animal model. FAM227B was found to be upregulated in LOXL2 knockdown. Knocking down LOXL2 results in lower levels of H3K4ox, resulting in chromatin decompaction, thus continuing activation of DNA damage response. This results in anticancer agents being more effective against cancerous cell lines. FAM227B was found to be a genetic risk variant in breast cancer. FAM227B was differentially expressed in prostrate genes of Esr2 knockout rats compared to wildtype rats. Esr2 is involved in anti-proliferation and differentiation. FAM227B was part of 20 upregulated genes in chorionic girdle during trophoblast development in horses. Protein FAM227B was differentially expressed in cardiovascular disease. FAM227B was found to be a candidate causal gene for lung cancer. FAM227B has a predicted p53 binding site.